相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
Panpan Zhou et al.
IMMUNITY (2023)
Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
Yanjia Chen et al.
NATURE REVIEWS IMMUNOLOGY (2023)
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection A Randomized Clinical Trial
Meagan P. O'Brien et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention
Sharana Mahomed et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Nature does things well
[Anonymous]
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
Wesley H. Self et al.
LANCET INFECTIOUS DISEASES (2022)
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
Peter B. Gilbert et al.
SCIENCE (2022)
Virus neutralisation by intracellular antibodies
Maria Bottermann et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2022)
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
Anil Gupta et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Inflammasome activation in infected macrophages drives COVID-19 pathology
Esen Sefik et al.
NATURE (2022)
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
Caroline Junqueira et al.
NATURE (2022)
Pan-coronavirus vaccine pipeline takes form
Elie Dolgin
NATURE REVIEWS DRUG DISCOVERY (2022)
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants
Laura L. Hammitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells
Jeremy Dufloo et al.
NATURE COMMUNICATIONS (2022)
Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms
Thandeka Moyo-Gwete et al.
SCIENTIFIC REPORTS (2022)
The epitope arrangement on flavivirus particles contributes to Mab C10's extraordinary neutralization breadth across Zika and dengue viruses
Arvind Sharma et al.
CELL (2021)
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
Robert L. Gottlieb et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
Alexandra Schafer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer et al.
NATURE MEDICINE (2021)
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
D. M. Weinreich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
Yunjiao Zhou et al.
CELL REPORTS (2021)
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Emma S. Winkler et al.
CELL (2021)
Role of the complement system in antibody-dependent enhancement of flavivirus infections
Alana B. Byrne et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
Anil Gupta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Variant-proof vaccines - invest now for the next pandemic
Dennis R. Burton et al.
NATURE (2021)
How Antibodies Recognize Pathogenic Viruses: Structural Correlates of Antibody Neutralization of HIV-1, SARS-CoV-2, and Zika
Morgan E. Abernathy et al.
VIRUSES-BASEL (2021)
Revisiting an IgG Fc Loss-of-Function Experiment: the Role of Complement in HIV Broadly Neutralizing Antibody b12 Activity
Benjamin S. Goldberg et al.
MBIO (2021)
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies
Renhong Yan et al.
CELL RESEARCH (2021)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury et al.
NATURE MEDICINE (2021)
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
L. Corey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primates
Lars Hangartner et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection
Bishal Marasini et al.
AIDS (2021)
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
Dapeng Li et al.
CELL (2021)
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress
Lauren E. Williamson et al.
CELL (2021)
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities
Myron S. Cohen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants
Zhiqiang Ku et al.
NATURE (2021)
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
M. Dougan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
M. P. O'Brien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
Meng Yuan et al.
SCIENCE (2021)
Amping up HIV antibodies
Dennis R. Burton
SCIENCE (2021)
Antibody fucosylation predicts disease severity in secondary dengue infection
Stylianos Bournazos et al.
SCIENCE (2021)
Evidence for antibody as a protective correlate for COVID-19 vaccines
Kristen A. Earle et al.
VACCINE (2021)
Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections
Shamus P. Keeler et al.
VIRUSES-BASEL (2021)
HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function
Simone I. I. Richardson et al.
FRONTIERS IN IMMUNOLOGY (2021)
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
Hannah L. Turner et al.
SCIENCE ADVANCES (2021)
Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19
Raymund R. Razonable et al.
ECLINICALMEDICINE (2021)
Is a Universal Influenza Virus Vaccine Possible?
Raffael Nachbagauer et al.
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
Can we use structural knowledge to design a protective vaccine against HIV-1?
Pamela J. Bjorkman
HLA (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Rational Vaccine Design in the Time of COVID-19
Dennis R. Burton et al.
CELL HOST & MICROBE (2020)
Rapid COVID-19 vaccine development
Barney S. Graham
SCIENCE (2020)
Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding
Lauren E. Gentles et al.
VIRUSES-BASEL (2020)
HOW BLOOD FROM COVID-19 SURVIVORS MIGHT SAVE LIVES
Amy Maxmen
NATURE (2020)
Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation
Fabian Junker et al.
FRONTIERS IN IMMUNOLOGY (2020)
Broadly neutralizing antibodies potently inhibit cell-to-cell transmission of semen leukocyte-derived SHIV162P3
Karunasinee Suphaphiphat et al.
EBIOMEDICINE (2020)
Recent successes in therapeutics for Ebola virus disease: no time for complacency
Patrick L. Iversen et al.
LANCET INFECTIOUS DISEASES (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Ann M. Arvin et al.
NATURE (2020)
Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
Mangaiarkarasi Asokan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivo
Pengfei Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Broad neutralization of SARS-related viruses by human monoclonal antibodies
Anna Z. Wec et al.
SCIENCE (2020)
Intracellular neutralisation of rotavirus by VP6-specific IgG
Sarah L. Caddy et al.
PLOS PATHOGENS (2020)
Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection
Stylianos Bournazos et al.
NATURE (2020)
Structural basis of Chikungunya virus inhibition by monoclonal antibodies
Qun Fei Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
Cathrine Scheepers et al.
CELL REPORTS (2020)
The role of IgG Fc receptors in antibody-dependent enhancement
Stylianos Bournazos et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
Alexandra C. Walls et al.
CELL (2019)
An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes
Adam S. Dingens et al.
IMMUNITY (2019)
Antibody responses to viral infections: a structural perspective across three different enveloped viruses
Charles D. Murin et al.
NATURE MICROBIOLOGY (2019)
Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
Marina Caskey et al.
NATURE MEDICINE (2019)
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge
Amarendra Pegu et al.
CELL HOST & MICROBE (2019)
Differential requirements for FcγR engagement by protective antibodies against Ebola virus
Stylianos Bournazos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Understudied Factors Influencing Fc-Mediated Immune Responses against Viral Infections
Sai Priya Anand et al.
VACCINES (2019)
Broadly protective human antibodies that target the active site of influenza virus neuraminidase
Daniel Stadlbauer et al.
SCIENCE (2019)
Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice
Iuliia M. Gilchuk et al.
CELL HOST & MICROBE (2019)
Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques
Matthew S. Parsons et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Yushun Wan et al.
JOURNAL OF VIROLOGY (2019)
IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody
Simone I. Richardson et al.
PLOS PATHOGENS (2019)
Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
Matthew Zirui Tay et al.
FRONTIERS IN IMMUNOLOGY (2019)
Application of Area Scaling Analysis to Identify Natural Killer Cell and Monocyte Involvement in the GranToxiLux Antibody Dependent Cell-Mediated Cytotoxicity Assay
Justin Pollara et al.
CYTOMETRY PART A (2018)
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
Peter D. Kwong et al.
IMMUNITY (2018)
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates
Kristen E. Pascal et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA
Sandhya Bangaru et al.
NATURE COMMUNICATIONS (2018)
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Jeremy Dufloo et al.
RETROVIROLOGY (2018)
The Many Faces of a Dynamic Virion: Implications of Viral Breathing on Flavivirus Biology and Immunogenicity
Kimberly A. Dowd et al.
ANNUAL REVIEW OF VIROLOGY, VOL 5 (2018)
Passive immunotherapy of viral infections: 'super-antibodies' enter the fray
Laura M. Walker et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Beyond binding: antibody effector functions in infectious diseases
Lenette L. Lu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Fcγ Receptor Function and the Design of Vaccination Strategies
Stylianos Bournazos et al.
IMMUNITY (2017)
The quest for an antibody-based HIV vaccine
Barton F. Haynes et al.
IMMUNOLOGICAL REVIEWS (2017)
Antibody Distance from the Cell Membrane Regulates Antibody Effector Mechanisms
Kirstie L. S. Cleary et al.
JOURNAL OF IMMUNOLOGY (2017)
In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice
Troy C. Sutton et al.
JOURNAL OF VIROLOGY (2017)
Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs
Hongru Li et al.
JOURNAL OF VIROLOGY (2017)
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants
Qing Zhu et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise
Dennis R. Burton
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Human Immunodeficiency Virus type-1 (HIV-1) evades antibody-dependent phagocytosis
Johannes S. Gach et al.
PLOS PATHOGENS (2017)
Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters
Oliver F. Brandenberg et al.
PLOS PATHOGENS (2017)
Of Mice, Macaques, and Men: Broadly Neutralizing Antibody Immunotherapy for HIV-1
Yoshiaki Nishimura et al.
CELL HOST & MICROBE (2017)
Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice
Teddy John Wohlbold et al.
JOURNAL OF VIROLOGY (2016)
Swine TRIM21 restricts FMDV infection via an intracellular neutralization mechanism
Wenchun Fan et al.
ANTIVIRAL RESEARCH (2016)
A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans
Devin Sok et al.
IMMUNITY (2016)
Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity
Laura A. VanBlargan et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2016)
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Davide Corti et al.
SCIENCE (2016)
Fusion of the mouse IgG1 Fc domain to the VHH fragment (ARP1) enhances protection in a mouse model of rotavirus
Gokce Gunaydin et al.
SCIENTIFIC REPORTS (2016)
Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses
Matthew Zirui Tay et al.
PLOS PATHOGENS (2016)
Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect
David J. DiLillo et al.
CELL (2015)
The role of Fc-FcγR interactions in IgG-mediated microbial neutralization
Stylianos Bournazos et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity
Feng Long et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
Antonietta Impagliazzo et al.
SCIENCE (2015)
Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike
Jeong Hyun Lee et al.
NATURE COMMUNICATIONS (2015)
Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis
Jing Jin et al.
CELL REPORTS (2015)
TRIM21 Promotes cGAS and RIG-I Sensing of Viral Genomes during Infection by Antibody-Opsonized Virus
Ruth E. Watkinson et al.
PLoS Pathogens (2015)
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
Laura E. McCoy et al.
PLOS PATHOGENS (2015)
Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent
Lucia Reh et al.
PLOS PATHOGENS (2015)
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Stylianos Bournazos et al.
CELL (2014)
High-Multiplicity HIV-1 Infection and Neutralizing Antibody Evasion Mediated by the Macrophage-T Cell Virological Synapse
Christopher J. A. Duncan et al.
JOURNAL OF VIROLOGY (2014)
Particle Conformation Regulates Antibody Access to a Conserved GII.4 Norovirus Blockade Epitope
Lisa C. Lindesmith et al.
JOURNAL OF VIROLOGY (2014)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
Motavizumab Treatment of Infants Hospitalized With Respiratory Syncytial Virus Infection Does Not Decrease Viral Load or Severity of Illness
Octavio Ramilo et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Complement-Mediated Virus Infectivity Neutralisation by HLA Antibodies Is Associated with Sterilising Immunity to SIV Challenge in the Macaque Model for HIV/AIDS
Mark Page et al.
PLOS ONE (2014)
Modeling Neutralization Kinetics of HIV by Broadly Neutralizing Monoclonal Antibodies in Genital Secretions Coating the Cervicovaginal Mucosa
Scott A. McKinley et al.
PLOS ONE (2014)
Lack of Protection following Passive Transfer of Polyclonal Highly Functional Low-Dose Non-Neutralizing Antibodies
Anne-Sophie Dugast et al.
PLOS ONE (2014)
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor
Amarendra Pegu et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
Ming Shum Yip et al.
VIROLOGY JOURNAL (2014)
Antibody to gp41 MPER Alters Functional Properties of HIV-1 Env without Complete Neutralization
Arthur S. Kim et al.
PLOS PATHOGENS (2014)
Broadly Neutralizing Antiviral Antibodies
Davide Corti et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
HIV-Specific Antibody Immunity Mediated Through NK Cells and Monocytes
Marit Kramski et al.
CURRENT HIV RESEARCH (2013)
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
Masashi Shingai et al.
NATURE (2013)
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
Dan H. Barouch et al.
NATURE (2013)
Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization
Boerries Brandenburg et al.
PLOS ONE (2013)
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
Jason S. McLellan et al.
SCIENCE (2013)
Cell-to-cell spread of HIV-1 and evasion of neutralizing antibodies
Torben Schiffner et al.
VACCINE (2013)
Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans
Jean-Philippe Julien et al.
PLOS PATHOGENS (2013)
Kinetic mechanism for HIV-1 neutralization by antibody 2G12 entails reversible glycan binding that slows cell entry
Emily J. Platt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody
Daniela Tudor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Highly Conserved Protective Epitopes on Influenza B Viruses
Cyrille Dreyfus et al.
SCIENCE (2012)
Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
Dennis R. Burton et al.
SCIENCE (2012)
Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature
Michelle C. Sabo et al.
VIROLOGY (2012)
Cell-Cell Transmission Enables HIV-1 to Evade Inhibition by Potent CD4bs Directed Antibodies
Irene A. Abela et al.
PLOS PATHOGENS (2012)
MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
Claudia R. Ruprecht et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
Margaret E. Ackerman et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH-and Cysteine Protease-Independent FcγR Pathway
Martial Jaume et al.
JOURNAL OF VIROLOGY (2011)
Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody
Dennis R. Burton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Robert Pejchal et al.
SCIENCE (2011)
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Damian C. Ekiert et al.
SCIENCE (2011)
Antibody-mediated neutralization of flaviviruses: A reductionist view
Kimberly A. Dowd et al.
VIROLOGY (2011)
A Dynamic Landscape for Antibody Binding Modulates Antibody-Mediated Neutralization of West Nile Virus
Kimberly A. Dowd et al.
PLOS PATHOGENS (2011)
In Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection
Patricia M. Day et al.
CELL HOST & MICROBE (2010)
Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L
Ann J. Hessell et al.
JOURNAL OF VIROLOGY (2010)
Treatment of respiratory syncytial virus with palivizumab: a systematic review
Jia Hu et al.
WORLD JOURNAL OF PEDIATRICS (2010)
Few and Far Between: How HIV May Be Evading Antibody Avidity
Joshua S. Klein et al.
PLOS PATHOGENS (2010)
Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a vaccinal effect of rituximab
Shannon P. Hilchey et al.
BLOOD (2009)
Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus
Erin Mehlhop et al.
CELL HOST & MICROBE (2009)
The Human Immunodeficiency Virus Type 1 Envelope Spike of Primary Viruses Can Suppress Antibody Access to Variable Regions
Ralph Pantophlet et al.
JOURNAL OF VIROLOGY (2009)
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
Ann J. Hessell et al.
NATURE MEDICINE (2009)
Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10
Joshua S. Klein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes
Bruce S. Thompson et al.
PLOS PATHOGENS (2009)
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
Ann J. Hessell et al.
PLOS PATHOGENS (2009)
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
Shee-Mei Lok et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner
Erin Mehlhop et al.
CELL HOST & MICROBE (2007)
Infectivity and neutralization of simian immunodeficiency virus with FLAG epitope insertion in gp120 variable loops
Melissa E. Laird et al.
JOURNAL OF VIROLOGY (2007)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII- dependent entry into B cells in vitro
Yin Wing Kam et al.
VACCINE (2007)
Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1
PL Moore et al.
JOURNAL OF VIROLOGY (2006)
Mechanism for complement-mediated, antibody-dependent enhancement of Human Immunodeficiency Virus type 1 infection in MT2 cells is enhanced entry through CD4, CD21, and CXCR4 chemokine receptors
W. Edward Robinson
VIRAL IMMUNOLOGY (2006)
An unrelated monoclonal antibody neutralizes human immunodeficiency virus type 1 by binding to an artificial epitope engineered in a functionally neutral region of the viral envelope glycoproteins
XP Ren et al.
JOURNAL OF VIROLOGY (2005)
The complement system in regulation of adaptive immunity
MC Carroll
NATURE IMMUNOLOGY (2004)
Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton
T Igakura et al.
SCIENCE (2003)
Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies
P Poignard et al.
JOURNAL OF VIROLOGY (2003)
Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120
R Pantophlet et al.
JOURNAL OF VIROLOGY (2003)
Nonneutralizing antibodies to the CD4-binding site on the gp120 subunit of human immunodeficiency virus type 1 do not interfere with the activity of a neutralizing antibody against the same site
C Herrera et al.
JOURNAL OF VIROLOGY (2003)
Antibody-dependent enhancement of virus infection and disease
SMC Tirado et al.
VIRAL IMMUNOLOGY (2003)
Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications
A Takada et al.
REVIEWS IN MEDICAL VIROLOGY (2003)
Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1
RW Sanders et al.
JOURNAL OF VIROLOGY (2002)
Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody
PWHI Parren et al.
JOURNAL OF VIROLOGY (2002)
A novel virus capture assay reveals a differential acquisition of host HLA-DR by clinical isolates of human immunodeficiency virus type 1 expanded in primary human cells depending on the nature of producing cells and the donor source
R Cantin et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 the presence of natural-killer effector cells
DN Forthal et al.
JOURNAL OF VIROLOGY (2001)
Human antibodies to major histocompatibility complex alloantigens mediate lysis and neutralization of HIV-1 primary isolate virions in the presence of complement
GT Spear et al.
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2001)
分享论文
